Effects of the Mutant TP53 Reactivator APR-246 on Therapeutic Sensitivity of Pancreatic Cancer Cells in the Presence and Absence of WT-TP53

Abrams, Stephen L.Akula, Shaw M.Steelman, Linda S.McCubrey, James A.2022-11-112022-11-112022-02-242073-4409http://hdl.handle.net/10342/11732en-USmutant TP53 reactivatorsnutlin-3atargeted therapyEffects of the Mutant TP53 Reactivator APR-246 on Therapeutic Sensitivity of Pancreatic Cancer Cells in the Presence and Absence of WT-TP53Article10.3390/cells11050794